INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

10943	Companies
239144	Keywords
167982	Articles
128574	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 02/20/2025 at 22:00, 1 year 6 months ago

Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial
Inventiva and Hepalys Pharma, Inc. initiate clinical development program of lanifibranor in Japan with dosing of first participant in Phase 1 trial, marking significant progress in partnership

Clinical Trial Japan Inventiva Lanifibranor Hepalys Pharma
BRIEF

published on 02/10/2025 at 22:05, 1 year 6 months ago

Inventiva annonce ses résultats financiers préliminaires pour 2024

Stratégie Résultats Financiers Financement Inventiva Lanifibranor
BRIEF

published on 02/10/2025 at 22:05, 1 year 6 months ago

Inventiva Announces Preliminary Financial Results for 2024

Financial Results Funding Strategy Inventiva Lanifibranor
PRESS RELEASE

published on 02/10/2025 at 22:00, 1 year 6 months ago

Inventiva publie ses résultats financiers préliminaires pour l'exercice fiscal 2024¹ et fait le point sur son activité
Inventiva publie ses résultats financiers préliminaires pour l'exercice fiscal 2024, met à jour son activité et annonce une réorganisation stratégique

Résultats Financiers Biopharmaceutique Reorganisation Inventiva Lanifibranor
PRESS RELEASE

published on 02/10/2025 at 22:00, 1 year 6 months ago

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update
Inventiva reports preliminary 2024 fiscal year financial results and business update, with €9.2 million revenues and €96.6 million cash as of December 31, 2024. Focused on lanifibranor development

Revenues Financial Results 2024 Fiscal Year Inventiva Lanifibranor
BRIEF

published on 01/24/2025 at 22:05, 1 year 7 months ago

Bilan semestriel du contrat de liquidité d'Inventiva avec Kepler Cheuvreux

Contrat De Liquidité Kepler Cheuvreux Biopharmaceutique Transactions Boursières Inventiva
BRIEF

published on 01/24/2025 at 22:05, 1 year 7 months ago

Half-yearly report on Inventiva's liquidity contract with Kepler Cheuvreux

Liquidity Contract Kepler Cheuvreux Biopharmaceutical Stock Market Transactions Inventiva
PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 7 months ago

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
Inventiva publie son bilan semestriel du contrat de liquidité avec Kepler Cheuvreux. Espèces de 349 630,55 € et 113 452 actions Inventiva au 31/12/2024. Analyse des transactions du semestre. Entreprise biopharmaceutique axée sur la stéatohépatite et autres maladies

Contrat De Liquidité Bilan Semestriel Kepler Cheuvreux Biopharmaceutique Inventiva
PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 7 months ago

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva announces half-year liquidity contract review with Kepler Cheuvreux. Cash and shares available in the liquidity account disclosed. Company focuses on developing oral small molecule therapies for MASH and unmet medical needs

Liquidity Contract Kepler Cheuvreux Clinical-Stage Biopharmaceutical Inventiva MASH
BRIEF

published on 01/22/2025 at 22:05, 1 year 7 months ago

Inventiva's LEGEND Trial Results to be Presented at EASL SLD Summit 2025

Lanifibranor Empagliflozin LEGEND Trial MASH Treatment EASL Summit 2025

Accesswire

Published on 09/08/2026 at 09:05, 1 hour 15 minutes ago

Battery X Metals to Appoint Accomplished Technology and Consumer Brands Executive Nicholas Reichenbach to Board of Directors
Published on 09/08/2026 at 09:05, 1 hour 15 minutes ago

BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study
Published on 09/08/2026 at 09:01, 1 hour 19 minutes ago

Apex Expands Trinity Zone with Step-out Hole Returning 197.5 m Interval of 2.12% REO at the Rift Rare Earth Project in SE Nebraska
Published on 09/08/2026 at 01:45, 8 hours 35 minutes ago

Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days 6 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update

View all ACCESSWIRE

EQS Group

Published on 09/08/2026 at 10:14, 6 minutes ago

TerraMaster Photos bénéficie d’une mise à niveau majeure, pour faciliter la consultation et l’organisation des photos
Published on 09/08/2026 at 10:08, 11 minutes ago

HEROSAN Launches Crowdfunding Campaign on Invesdor
Published on 09/08/2026 at 10:05, 15 minutes ago

JOHNNIE WALKER DROPS LIMITED EDITION SABRINA CARPENTER BLACK LABEL BOTTLE DESIGN
Published on 09/08/2026 at 10:01, 19 minutes ago

PSI enters into a Delisting Agreement with Warburg Pincus; Warburg Pincus announces public delisting acquisition offer for PSI Software SE
Published on 09/08/2026 at 10:00, 20 minutes ago

Karlsberg Brauerei publishes half-year figures for 2026

Les Echos

Published on 09/08/2026 at 08:30, 1 hour 50 minutes ago

Klarsen : calendrier de communication
Published on 09/07/2026 at 19:55, 14 hours 24 minutes ago

TFF GROUP CREE TFF UPCYCLING
Published on 09/07/2026 at 19:00, 15 hours 20 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 15 hours 20 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 16 hours 15 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026

View all LES ECHOS COMFI WIRE